Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized study (1: 1), open-label, controlled, phase 3, multicenter,
non-profit. The hypothesis of the present study is that bictegravir is associated with a
lower incidence and severity of neuropsychiatric symptoms than dolutegravir.
Phase:
Phase 3
Details
Lead Sponsor:
Azienda Ospedaliera Universitaria Senese
Collaborators:
Azienda Ospedaliera San Paolo Catholic University of the Sacred Heart Ospedale Amedeo di Savoia Ospedale Policlinico San Martino